Geert Kersten is the founder of CEL-SCI. Latest round: Growth. Based in Vienna, Austria.
Geert R. Kersten is the Chief Executive Officer and Director of CEL-SCI Corporation, a biotechnology company focused on developing immunotherapy treatments for cancer. He has guided the company through a significant Phase 3 clinical trial for Multikine, which focused on head and neck cancer and showed improved survival outcomes. Kersten has also personally invested in CEL-SCI stock on multiple occasions.
Full founder directory · Investor directory · Company funding database · Fundraising library